Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)
PHASE1CompletedINTERVENTIONAL
Enrollment
363
Participants
Timeline
Start Date
June 30, 2015
Primary Completion Date
March 10, 2020
Study Completion Date
March 10, 2020
Conditions
Brain Tumor, PrimaryBrain Tumor, Recurrent
Interventions
DRUG
Indocyanine Green
Indocyanine Green
All Listed Sponsors
lead
University of Pennsylvania
OTHER
NCT03262636 - Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) | Biotech Hunter | Biotech Hunter